Galderma Group N
CHCHFGalderma Group N (SW:GALD) — Drug Manufacturers - Specialty & Generic. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om virksomheden
- Websted
- galderma.com
- Investorrelationer
- investors.galderma.com/
- Sektor
- Healthcare · Drug Manufacturers - Specialty & Generic
- Hovedkontor
- NEW YORK, Switzerland
- Administrerende direktør
- Dr. Flemming Ornskov M.B.A., M.D., M.P.H.
- Ansatte
- 7 676
- Børsnoteret siden
- 21.03.2024 (SW:GALD)
- Udestående aktier
- 233.19 mio.
- Free float
- 131.27 mio.
- Markedsværdi
- 37.96 mia. CHF
- Insidere
- 21%
- Institutionelle investorer
- 48.21%
Beskrivelse
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Udbytte
Galderma Group N (GALD) udbetaler udbytte uregelmæssigt. I løbet af de sidste 12 måneder blev der betalt 0.35 CHF pr. Aktie (betalinger: 1). Det svarer til cirka 0.22% af den nuværende aktiekurs. Baseret på betalingshistorikken forventes næste ex-udbyttedato omkring 23.04.2027.
| Ex-dato | Udbetaling | Beløb | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-04-24 | 2026-04-28 | 0.3500 CHF | 0.2/0.2 % | årlig | SW:GALD |
| 2025-04-25 | — | 0.1500 CHF | 0.1/0.1 % | årlig | SW:GALD |
Nyheder denne uge
Endnu ingen nyheder fra virksomhedens websted.
Største ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.14% | 2.72 mio. | 2026-07-31 |
| VANGUARD SPECIALIZED FUN… | 1.01% | 2.41 mio. | 2026-07-31 |
| VANGUARD WORLD FUND-Vang… | 0.93% | 2.22 mio. | 2026-05-31 |
| VANGUARD TAX-MANAGED FUN… | 0.76% | 1.81 mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 0.58% | 1.37 mio. | 2026-08-31 |
| Prudential World Fund, I… | 0.43% | 1.02 mio. | 2026-07-31 |
| Prudential World Fd., In… | 0.42% | 997 238 | 2026-07-31 |
| Fidelity Concord Street… | 0.3% | 722 551 | 2026-08-31 |
| iShares Trust-iShares MS… | 0.27% | 649 845 | 2026-08-31 |
| Legg Mason Global Asset… | 0.27% | 634 446 | 2026-07-31 |
| -iShares Flexible Equity… | 0.11% | 1.25 mio. | 2026-08-31 |
| Trust for Professional M… | 0% | 39 834 | 2026-05-31 |
| Rhumbline Advisers | 0% | 30 607 | 2026-06-30 |
| NORTHERN LIGHTS FUND TRU… | 0% | 18 396 | 2026-05-31 |
| -John Hancock Hedged Equ… | 0% | 8 059 | 2026-06-30 |
| PNC Financial Services G… | 0% | 3 224 | 2026-06-30 |
| RBB Fund, Inc.-Aquarius… | 0% | 1 615 | 2026-08-31 |
| Gamma Investing LLC | 0% | 1 270 | 2026-06-30 |
| Salomon & Ludwin, LLC | 0% | 789 | 2026-06-30 |
| IMA Advisory Services, I… | 0% | 268 | 2026-06-30 |
| -NPF Core Equity ETF | 0% | 219 | 2026-07-31 |
| Pacer Advisors, Inc. | 0% | 119 | 2026-06-30 |
